Ophthal Medical News about retina

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
2010 Part D May Hurt Low Income Patients

Dorothy J. Schirf, MD

Technology Advances

Groundbreaking Nanolaser Grants Access to DNA

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Vasoproliferative retinal tumours in a Swedish population
Acta Ophthalmologica, 11/06/09

Makdoumi K et al. – VPRTs are benign intraretinal changes. Several complications are associated with this condition. All patients in this study had symptom–giving tumours and six patients already had profound macular oedema at presentation. In these cases, when complications have already developed, the final visual prognosis is poor, thereby making it important to detect these tumours early. The patient who received anti–vascular endothelial growth factor therapy showed a slow improvement and distinct regression in exudations during the follow–up time. However, no increase in visual acuity was seen.

<< Previous
Retinal nerve fibre layer thickness in full-term children...

Next >>
Psychophysical assessment of low visual function in patients with...